Aspen Neuroscience
San Diego
About Aspen Neuroscience
Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical needs, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $387.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2025)
- Website: aspenneuroscience.com
- Phone: +1 858 263 1222
Industries & Categories
Biotechnology, Medical, Neuroscience, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aspen-neuroscience-59460 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.